Lamivudine resistance and exacerbation of hepatitis B in infliximab-treated Crohn's disease patient

被引：43

作者：

Esteve, Maria

Loras, Carme

Gonzalez-Huixt, Ferran

机构：

[1] Univ Barcelona, Hosp Mutua Terrassa, Dept Gastroenterol, Barcelona 08221, Catalonia, Spain

[2] Hosp Josep Truenta, Dept Gastroenterol, Girona, Catalonia, Spain

来源：

INFLAMMATORY BOWEL DISEASES | 2007年 / 13卷 / 11期

关键词：

D O I：

10.1002/ibd.20202

中图分类号：

R57 [消化系及腹部疾病];

学科分类号：

摘要：

引用

页码：1450 / 1451

页数：2

共 6 条

[1]

Management of chronic hepatitis B [J].

Conjeevaram, HS ;

Lok, ASF .

JOURNAL OF HEPATOLOGY, 2003, 38 :S90-S103

[2]

Clinical evolution of luminal and perianal Crohn's disease after inducing remission with infliximab:: how long should patients be treated? [J].

Domènech, E ;

Hinojosa, J ;

Nos, P ;

Garcia-Planella, E ;

Cabré, E ;

Bernal, I ;

Gassull, MA .

ALIMENTARY PHARMACOLOGY & THERAPEUTICS, 2005, 22 (11-12) :1107-1113

[3]

Chronic hepatitis B reactivation following infliximab therapy in Crohn's disease patients:: need for primary prophylaxis [J].

Esteve, M ;

Saro, C ;

González-Huix, F ;

Suarez, F ;

Forné, M ;

Viver, JM .

GUT, 2004, 53 (09) :1363-1365

[4]

Chronic hepatitis B [J].

Lok, Anna S. F. ;

McMahon, Brian J. .

HEPATOLOGY, 2007, 45 (02) :507-539

[5]

Chronic hepatitis B: Update of recommendations [J].

Lok, ASF ;

McMahon, BJ .

HEPATOLOGY, 2004, 39 (03) :857-861

[6]

Week 48 resistance surveillance in two phase 3 clinical studies of adefovir dipivoxil for chronic hepatitis B [J].

Westland, CE ;

Yang, HL ;

Delaney, WE ;

Gibbs, CS ;

Miller, MD ;

Wulfsohn, M ;

Fry, J ;

Brosgart, CL ;

Xiong, S .

HEPATOLOGY, 2003, 38 (01) :96-103

← 1 →